Amniotic fluid or placental CD117 stem cells therapy(Wake Forest University Health Sciences)

N/A

Report date: 2026/02/07 20:00:33

Base Information

Drug NameAmniotic fluid or placental CD117 stem cells therapy(Wake Forest University Health Sciences)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Source of cells > Placenta-derivedCell and gene therapy > Cell therapy > Source of cells > Amniotic fluid-derived

Mechanisms of ActionStem cell replacements

TargetsUpdating

Therapy Area/IndicationsMultiple Sclerosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesWake Forest University Health Sciences

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesWake Forest University Health Sciences

Active IndicationsN/A

Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A